Giovanna Gentile | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
The future of pharmacogenetics in the treatment of migraine	PHARMACOGENOMICS	2019
Genetics of Obstructive Sleep Apnea: Vitamin D Receptor Gene Variation Affects Both Vitamin D Serum Concentration and Disease Susceptibility	OMICS	2019
Tailoring Treatment in Polymorbid Migraine Patients through Personalized Medicine	CNS DRUGS	2018
Pharmacogenetic considerations for migraine therapies	EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY	2018
Single nucleotide polymorphism of gstp1 and pathological complete response in locally advanced rectal cancer patients treated with neoadjuvant concomitant radiochemotherapy	RADIATION ONCOLOGY JOURNAL	2018
Evaluation of 5-fluorouracil degradation rate and pharmacogenetic profiling to predict toxicity following adjuvant capecitabine	EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY	2017
Lasmiditan for the treatment of migraine	EXPERT OPINION ON INVESTIGATIONAL DRUGS	2017
Personalized medicine applied to forensic sciences: new advances and perspectives for a tailored forensic approach	CURRENT PHARMACEUTICAL BIOTECHNOLOGY	2017
Pharmacogenetic Approach to Toxicity in Breast Cancer Patients Treated with Taxanes	ANTICANCER RESEARCH	2017
Stable Remission of Multiple Chemical Sensitivity Syndrome and Major Depression With Citalopram and 1-Month Deep Transcranial Magnetic Stimulation. A Case Report	THE JOURNAL OF ECT	2017
Genetic association analysis of serotonin and signal transduction pathways in suicide attempters from an Italian sample of psychiatric patients	NEUROSCIENCE LETTERS	2017
Personalised healthcare: the DiMA clinical model	CURRENT PHARMACEUTICAL BIOTECHNOLOGY	2017
Pre-treatment evaluation of 5-fluorouracil degradation rate. association of poor and ultra-rapid metabolism with severe toxicity in a colorectal cancer patients cohort	ONCOTARGET	2016
CYP19A1 Genetic Polymorphisms rs4646 and Osteoporosis in Patients Treated with Aromatase Inhibitor-Based Adjuvant Therapy	THE EURASIAN JOURNAL OF MEDICINE	2016
Choosing the safest acute therapy during chronic migraine prophylactic treatment. pharmacokinetic and pharmacodynamic considerations	EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY	2016
The TYMS-TSER polymorphism is associated with toxicity of low-dose capecitabine in patients with advanced gastrointestinal cancer	ANTI-CANCER DRUGS	2016
Pre-treatment assay of 5-fluorouracil degradation rate (5-FUDR) to improve prediction of 5-fluorouracil toxicity in gastro-esophageal cancer	ONCOTARGET	2016
Degradation rate of 5-fluorouracil in metastatic colorectal cancer. A new predictive outcome biomarker?	PLOS ONE	2016
Eletriptan in the management of acute migraine. An update on the evidence for efficacy, safety, and consistent response	THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS	2016
Precise medical decision making in geriatric anti-depressant therapy	EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT	2016